Placid Jover - Aug 1, 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Executive Vice President, Chief Human Resources Officer.
Signature
/s/ Dov Bergwerk as attorney-in-fact for Placid Jover
Stock symbol
TEVA
Transactions as of
Aug 1, 2024
Transactions value $
$0
Form type
4
Date filed
8/5/2024, 07:32 AM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Award $0 +51.3K $0.00 51.3K Aug 1, 2024 Ordinary Shares 51.3K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F2 Restricted share units were granted on August 1, 2024, with 12,827 vesting on each of August 1, 2025, August 1, 2026 and August 1, 2027 and 12,830 vesting on August 1, 2028.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Remarks:

Executive Vice President, Chief Human Resources Officer.